The Supreme Administrative Court in the Czech Republic has asked the CJEU whether a substance classified as an excipient in a marketing authorisation can still be considered an active ingredient for an SPC application, and what information is needed for an additional active ingredient to be "specifically identifiable" based on the patent.
In recent years, greenwashing in cosmetics has come under increased legal scrutiny.
The UPC Court of Appeal has sided with the Düsseldorf Local Division in upholding a preliminary injunction granted in respect of sales of Mammut’s avalanche rescue device in Germany and Austria.
We are delighted to report that our client, Proteotype Diagnostics Ltd, has just been awarded a £1.5 million Cancer Mission Grant to advance the groundbreaking work they have been doing in early cancer detection with their innovative Enlighten™ test.
Potter Clarkson has once again been highly recognised in the 2025 Legal 500 rankings, a leading guide for clients seeking top law firms, attorneys, and solicitors.
The role of artificial intelligence (AI) in the health sector is expanding, aiming to bring personalised healthcare to a broader audience. In the realm of femtech (the term used to define software and services that use technology tailored towards women’s health), AI’s significance is particularly pronounced.